Nicolet Advisory Services’s Immunomedics Inc IMMU Stock Holding History

Nicolet Advisory Services’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27,830	Closed	-$2.37M	–	194
2020 Q3	$2.37M	Buy	27,830 +5,800	+26%	+$293K	0.37%	38
2020 Q2	$781K	Buy	22,030 +2,030	+10%	+$59.3K	0.12%	85
2020 Q1	$270K	Hold	20,000	–	–	0.05%	151
2019 Q4	$423K	Hold	20,000	–	–	0.07%	110
2019 Q3	$265K	Hold	20,000	–	–	0.04%	136
2019 Q2	$277K	Hold	20,000	–	–	0.04%	131
2019 Q1	$384K	Buy	+20,000	New	+$322K	0.07%	100

Nicolet Advisory Services's IMMU Position: Q4 2020 in Review

Nicolet Advisory Services sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 27,830 shares — an estimated $2.37M sold.

Nicolet Advisory Services first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $2.37M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Nicolet Advisory Services reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Nicolet Advisory Services sold 27,830 Immunomedics Inc shares in Q4 2020, an estimated $2.37M.
Nicolet Advisory Services first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
Nicolet Advisory Services's Immunomedics Inc position peaked at $2.37M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Nicolet Advisory Services's 13F filing for Q4 2020, filed 9 Feb 2021.